Google Blocked Access: Unusual Traffic Detected
A novel gene therapy, currently designated NTLA-2001, demonstrates promising results in treating hereditary transthyretin-mediated (hATTR) amyloidosis, a rare and often fatal disease. Published this week in The New England Journal ... Read More